A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia

JL Harousseau; JE Lancet; J Reiffers; Bob Löwenberg; X Thomas; F Huguet; P Fenaux; S Zhang; W Rackoff; P De Porre; R Stone

doi:10.1182/blood-2006-09-046144

A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia

JL Harousseau, JE Lancet, J Reiffers, Bob Löwenberg, X Thomas, F Huguet, P Fenaux, S Zhang, W Rackoff, P De Porre, R Stone

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

73 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	5151-5156
Number of pages	6
Journal	Blood
Volume	109
Issue number	12
DOIs	https://doi.org/10.1182/blood-2006-09-046144
Publication status	Published - 2007

Research programs

EMC MM-02-41-03

Access to Document

10.1182/blood-2006-09-046144

http://hdl.handle.net/1765/35368

Cite this

@article{e5e305a508b948c592494519892cd2f7,

title = "A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia",

author = "JL Harousseau and JE Lancet and J Reiffers and Bob L{\"o}wenberg and X Thomas and F Huguet and P Fenaux and S Zhang and W Rackoff and {De Porre}, P and R Stone",

year = "2007",

doi = "10.1182/blood-2006-09-046144",

language = "Undefined/Unknown",

volume = "109",

pages = "5151--5156",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "12",

}

TY - JOUR

T1 - A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia

AU - Harousseau, JL

AU - Lancet, JE

AU - Reiffers, J

AU - Löwenberg, Bob

AU - Thomas, X

AU - Huguet, F

AU - Fenaux, P

AU - Zhang, S

AU - Rackoff, W

AU - De Porre, P

AU - Stone, R

PY - 2007

Y1 - 2007

U2 - 10.1182/blood-2006-09-046144

DO - 10.1182/blood-2006-09-046144

M3 - Article

C2 - 17351110

SN - 0006-4971

VL - 109

SP - 5151

EP - 5156

JO - Blood

JF - Blood

IS - 12

ER -